financetom
Business
financetom
/
Business
/
Update: Alaska Air Group Flight Attendants to Earn 32% Pay Raise Under New Labor Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Alaska Air Group Flight Attendants to Earn 32% Pay Raise Under New Labor Deal
Jul 3, 2024 9:31 AM

12:06 PM EDT, 07/03/2024 (MT Newswires) -- (Updates with Alaska Airlines comment in last paragraph.)

Alaska Air Group's ( ALK ) Alaska Airlines' flight attendants will receive an average pay raise of 32% and guaranteed boarding pay under a tentative three-year labor deal, according to the Association of Flight Attendants, which represents the workers.

The labor union said the deal was reached after "20 months of hard bargaining" and that it is the first airline to guarantee boarding pay in a legally binding contract.

Other aspects of the tentative deal include boarding pay increases ranging from 4.6% to 33.6%, a 401(k) match increase, and 21 months of retro pay.

The agreement must be ratified by the members of the flight attendants union before it becomes binding.

"We're pleased to reach a deal with AFA and look forward to our flight attendants working under a new contract as soon as possible," a representative for Alaska Airlines said in an emailed statement.

Price: 39.96, Change: +0.23, Percent Change: +0.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcutis Biotherapeutics Signs Co-Promote Deal for Zoryve With Kowa Pharmaceuticals; Shares Down
Arcutis Biotherapeutics Signs Co-Promote Deal for Zoryve With Kowa Pharmaceuticals; Shares Down
Jul 29, 2024
11:00 AM EDT, 07/29/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Monday it signed a co-promotion agreement for the Zoryve products with Kowa Pharmaceuticals America. Financial terms weren't disclosed. Kowa will market and promote the Zoryve cream and foam to primary care practitioners and pediatricians for all US Food and Drug Administration-approved indications, while Arcutis will have the...
Eni's 'Satellite' Strategy Boosts Valuation, Accelerates Debt Reduction, RBC Says
Eni's 'Satellite' Strategy Boosts Valuation, Accelerates Debt Reduction, RBC Says
Jul 29, 2024
11:01 AM EDT, 07/29/2024 (MT Newswires) -- Eni (E) is showing progress in its satellite strategy for the energy transition by selling parts of its companies Plenitude and Enilive at much higher prices than their current value, which will help its debt and make its distribution plans more defensive compared to its competitors, RBC Capital Markets said in a note...
Syndax Pharmaceuticals Says US FDA Extends Revumenib Review; Shares Fall
Syndax Pharmaceuticals Says US FDA Extends Revumenib Review; Shares Fall
Jul 29, 2024
11:00 AM EDT, 07/29/2024 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) said Monday the US Food and Drug Administration has extended the Prescription Drug User Fee Act, or PDUFA, action date for the new drug application for revumenib, providing the regulator more time to review additional data. The filing of supplemental information to the regulator was considered a major...
Textron's Aviation Unit to Sell Three Beechcraft King Air 360C Aircraft to Gama Aviation
Textron's Aviation Unit to Sell Three Beechcraft King Air 360C Aircraft to Gama Aviation
Jul 29, 2024
11:01 AM EDT, 07/29/2024 (MT Newswires) -- Textron's ( TXT ) Textron Aviation unit said Monday it has signed an agreement with Gama Aviation to sell Gama three cargo door-equipped Beechcraft King Air 360C aircraft. Financial terms of the agreement weren't disclosed. Textron Aviation said it intends to deliver the aircraft next year. The aircraft is intended to help support...
Copyright 2023-2026 - www.financetom.com All Rights Reserved